We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

21 Aug 2018 15:28

RNS Number : 4726Y
Sensyne Health PLC
21 August 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Sensyne Health Ltd

Sedol BYV3J75

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Placing of shares

X

3. Details of person subject to the notification obligationiv

Name

1Lansdowne Partners International Limited

2Lansdowne Partners Limited

3Lansdowne Partners (UK) LLP

4Lansdowne Developed Markets Master Fund Limited

 

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Aurora Nominees Ltd

Morgan Stanley Client Securities Nominees Ltd

(Registered Shareholders)

City and country of registered office (if applicable)

n/a

5. Date on which the threshold was crossed or reachedvi:

17/08/2018

6. Date on which issuer notified (DD/MM/YYYY):

20/08/2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

10.41%

10.41%

128,571,514

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BYV3J755

13,384,497

10.41%

SUBTOTAL 8. A

13,384,497

10.41%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Lansdowne Partners

International Limited

10.41%

10.41%

Lansdowne Partners

Limited

Lansdowne Partners (UK) LLP

10.41%

10.41%

Lansdowne Developed Markets Master Fund Limited

9.03%

9.03%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London

Date of completion

20 August 2018

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLZMGZRDMVGRZM
Date   Source Headline
31st Jul 20197:00 amRNSCollaboration Agreement with Bayer
9th Jul 20197:00 amRNSHoldings in Company
1st Jul 20192:05 pmRNSSecond Price Monitoring Extn
1st Jul 20192:00 pmRNSPrice Monitoring Extension
27th Jun 20194:48 pmRNSHolding(s) in Company
27th Jun 20194:42 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSEY announcement on AI and blockchain
24th Jun 20197:00 amRNSLAB10x partnership for data-driven drug discovery
30th Apr 20197:00 amRNSBayer joins Sensyne Health consortium
28th Jan 20197:02 amRNSResearch alliance with Big Data Institute
28th Jan 20197:02 amRNSAgreement with Jefferson Health in US
28th Jan 20197:02 amRNSSigns SRA with Wye Valley NHS Trust
28th Jan 20197:02 amRNSSigns SRA with George Eliot Hospital NHS Trust
28th Jan 20197:02 amRNSSensyne Health Maiden Interim Results 2018
15th Jan 20197:00 amRNSNotice of Interim Results
5th Dec 201810:41 amRNSAnnouncement on National Health Data
21st Nov 20187:00 amRNSStrategic advisory services agreement with EY
24th Oct 20187:00 amRNSBoard Change
16th Oct 20187:00 amRNSOfficial product launch of GDm-HealthT
3rd Oct 20187:00 amRNSBoard Appointment
2nd Oct 20187:00 amRNSChange of Registered Office
28th Sep 201811:56 amRNSHolding(s) in Company
6th Sep 20181:19 pmRNSSensyne Health welcomes government code of conduct
21st Aug 20183:28 pmRNSHoldings in Company
20th Aug 20185:32 pmRNSHoldings in Company
20th Aug 20184:52 pmRNSHoldings in Company
17th Aug 20188:04 amRNSAdmission to AIM & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.